MD Anderson Cancer Center at Cooper is a clinical research site located in Camden, New Jersey, United States 08103.
Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.
MD Anderson Cancer Center at Cooper has participated in 32 clinical trials with 13 currently active.
Therapeutic areas: Metastatic Melanoma, Unresectable Melanoma, Melanoma.
Sponsors: Iovance Biotherapeutics, Inc., Pfizer, Merck Sharp & Dohme LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Camden
Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MD Anderson Cancer Center at Cooper has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MD Anderson Cancer Center at Cooper has 32 clinical trials on record, with 13 currently active. Their work covers Metastatic Melanoma, Unresectable Melanoma, Melanoma.
MD Anderson Cancer Center at Cooper has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.